ACET
Adicet Bio, Inc. NASDAQ Listed Jan 26, 2018$8.32
After hrs
$8.55
+0.00%
Mkt Cap $79.8M
52w Low $6.01
20.2% of range
52w High $17.44
50d MA $7.35
200d MA $9.74
P/E (TTM)
-0.5x
EV/EBITDA
-0.3x
P/B
0.3x
Debt/Equity
0.1x
ROE
-73.4%
P/FCF
-0.6x
RSI (14)
—
ATR (14)
—
Beta
1.58
50d MA
$7.35
200d MA
$9.74
Avg Volume
149.9K
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is based in Boston, Massachusetts.
200 Clarendon Street · Boston, MA 02116 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | AMC | -3.23 | -2.94 | +9.0% | 7.04 | -0.9% | +2.4% | +1.8% | +2.1% | -1.6% | +0.4% | — |
| Nov 5, 2025 | AMC | -4.16 | -4.64 | -11.5% | 11.04 | +0.0% | -1.9% | -7.3% | -4.8% | -6.3% | -0.5% | — |
| Aug 7, 2025 | AMC | -5.12 | -5.44 | -6.2% | 10.99 | -1.0% | -9.6% | -13.2% | -7.0% | -0.1% | -5.4% | — |
| May 6, 2025 | AMC | -5.44 | -4.96 | +8.8% | 9.64 | -0.4% | -18.6% | -20.6% | +1.2% | +19.7% | +10.9% | — |
| Mar 6, 2025 | AMC | -5.92 | -5.12 | +13.5% | 13.54 | -3.1% | -5.9% | -9.8% | -6.8% | -6.2% | -8.3% | — |
| Nov 6, 2024 | AMC | -5.76 | -5.44 | +5.6% | 20.80 | +0.0% | +2.3% | +0.8% | -3.1% | -7.7% | -12.3% | — |
| Aug 13, 2024 | AMC | -5.60 | -5.28 | +5.7% | 20.80 | +1.5% | +5.4% | +10.0% | +17.7% | +19.2% | +13.1% | — |
| May 14, 2024 | AMC | -5.60 | -5.60 | +0.0% | 21.28 | +6.0% | +5.3% | +18.0% | +20.3% | +21.8% | +21.1% | — |
| Mar 19, 2024 | AMC | -11.52 | -11.04 | +4.2% | 32.48 | +9.4% | +5.4% | +0.5% | +7.9% | +8.4% | +10.3% | — |
| Nov 8, 2023 | AMC | -11.68 | -11.36 | +2.7% | 21.28 | -2.3% | -6.0% | -9.8% | -11.3% | -11.3% | -9.0% | — |
| Aug 9, 2023 | AMC | -10.88 | -12.00 | -10.3% | 33.60 | -4.3% | +11.9% | +9.5% | +1.9% | +1.4% | -1.9% | — |
| May 9, 2023 | AMC | -11.84 | -11.52 | +2.7% | 107.68 | +3.4% | +3.0% | -1.0% | -5.5% | +5.9% | +1.5% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5 | Jefferies | Reiterates | Buy | $19 | $8.45 | $8.61 | +1.9% | +0.7% | +1.2% | -1.5% | — | — |
| Mar 23 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.92 | $6.82 | -1.4% | -3.8% | -3.3% | -1.6% | -2.7% | -6.5% |
| Mar 13 | Guggenheim | Maintains | Buy → Buy | — | $7.04 | $6.98 | -0.9% | +2.4% | +1.8% | +2.1% | -1.6% | +0.4% |
| Jan 21 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.90 | $8.13 | +2.9% | +2.2% | +6.3% | +6.8% | +10.1% | +8.1% |
| Jan 6 | Canaccord Genuity | Maintains | Buy → Buy | — | $8.15 | $8.10 | -0.6% | -1.2% | +3.7% | -0.7% | -1.5% | -4.2% |
| Nov 7 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $10.83 | $10.72 | -1.0% | -5.5% | -3.0% | -4.5% | +1.4% | -2.0% |
| Oct 8 | Guggenheim | Maintains | Buy → Buy | — | $13.65 | $13.76 | +0.8% | +8.9% | +7.2% | +13.4% | +14.8% | +12.5% |
| Sep 19 | Guggenheim | Maintains | Buy → Buy | — | $12.97 | $13.12 | +1.2% | -1.9% | +1.2% | +2.4% | +5.5% | +3.5% |
| Mar 21 | Guggenheim | Maintains | Buy → Buy | — | $12.23 | $12.23 | +0.0% | +0.2% | +19.6% | +15.8% | +17.3% | +11.2% |
| Mar 7 | Citizens Capital Markets | Maintains | Market Perform → Market Perform | — | $13.54 | $13.12 | -3.1% | -5.9% | -9.8% | -6.8% | -6.2% | -8.3% |
| Mar 7 | HC Wainwright & Co. | Maintains | Neutral → Neutral | — | $13.54 | $13.12 | -3.1% | -5.9% | -9.8% | -6.8% | -6.2% | -8.3% |
| Feb 27 | HC Wainwright & Co. | Maintains | Neutral → Neutral | — | $14.44 | $14.76 | +2.2% | -4.8% | -0.4% | -6.1% | -3.5% | -3.0% |
| Feb 6 | JMP Securities | Maintains | Market Perform → Market Perform | — | $16.16 | $15.68 | -3.0% | +2.0% | -4.5% | -10.9% | -10.8% | -14.2% |
| Feb 5 | HC Wainwright & Co. | Maintains | Neutral → Neutral | — | $14.72 | $15.97 | +8.5% | +9.8% | +12.0% | +4.9% | -2.2% | -2.0% |
| Dec 19 | HC Wainwright & Co. | Maintains | Neutral → Neutral | — | $14.33 | $14.72 | +2.7% | -4.0% | +1.6% | -0.2% | +2.3% | +7.2% |
| Aug 14 | Canaccord Genuity | Maintains | Buy → Buy | — | $20.80 | $21.12 | +1.5% | +5.4% | +10.0% | +17.7% | +19.2% | +13.1% |
| Aug 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $20.80 | $21.12 | +1.5% | +5.4% | +10.0% | +17.7% | +19.2% | +13.1% |
| Jul 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $17.12 | $19.20 | +12.1% | +9.3% | +13.1% | +18.7% | +17.8% | +13.1% |
| Jun 24 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $21.92 | $22.40 | +2.2% | +9.5% | +7.3% | -2.2% | -2.2% | -11.7% |
| Jun 5 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $21.76 | $22.88 | +5.1% | +5.9% | +2.9% | -0.7% | -3.7% | -5.1% |
| May 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $21.28 | $22.56 | +6.0% | +5.3% | +18.0% | +20.3% | +21.8% | +21.1% |
| Apr 23 | Wedbush | Maintains | Outperform → Outperform | — | $32.00 | $34.24 | +7.0% | +5.0% | -6.0% | -9.5% | -16.0% | -20.5% |
| Apr 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $38.40 | $37.60 | -2.1% | -1.7% | -5.8% | -5.0% | -6.2% | -9.2% |
| Mar 20 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $32.48 | $35.52 | +9.4% | +5.4% | +0.5% | +7.9% | +8.4% | +10.3% |
| Mar 20 | Canaccord Genuity | Maintains | Buy → Buy | — | $32.48 | $35.52 | +9.4% | +5.4% | +0.5% | +7.9% | +8.4% | +10.3% |
| Mar 20 | Wedbush | Maintains | Outperform → Outperform | — | $32.48 | $35.52 | +9.4% | +5.4% | +0.5% | +7.9% | +8.4% | +10.3% |
| Feb 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $49.44 | $48.80 | -1.3% | -2.9% | +1.0% | +3.2% | +3.9% | +9.4% |
| Jan 5 | Canaccord Genuity | Maintains | Buy → Buy | — | $34.56 | $33.76 | -2.3% | +12.0% | +13.9% | +59.7% | +55.1% | +40.7% |
| Nov 9 | Wedbush | Maintains | Outperform → Outperform | — | $21.28 | $20.80 | -2.3% | -6.0% | -9.8% | -11.3% | -11.3% | -9.0% |
| Sep 6 | Truist | Maintains | Buy → Buy | — | $29.76 | $29.44 | -1.1% | -2.7% | -4.3% | -9.1% | -8.6% | -14.0% |
| Aug 11 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $37.60 | $36.80 | -2.1% | -2.1% | -8.9% | -9.4% | -12.3% | -16.2% |
| Aug 10 | Wedbush | Maintains | Outperform → Outperform | — | $33.60 | $32.16 | -4.3% | +11.9% | +9.5% | +1.9% | +1.4% | -1.9% |
| Aug 10 | BTIG | Maintains | Buy → Buy | — | $33.60 | $32.16 | -4.3% | +11.9% | +9.5% | +1.9% | +1.4% | -1.9% |
| Jun 27 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $74.56 | $61.44 | -17.6% | -54.3% | -43.3% | -50.4% | -47.9% | -41.4% |
| Jun 27 | Guggenheim | Downgrade | Buy → Neutral | — | $74.56 | $61.44 | -17.6% | -54.3% | -43.3% | -50.4% | -47.9% | -41.4% |
| Jun 27 | JMP Securities | Downgrade | Market Outperform → Market Perform | — | $74.56 | $61.44 | -17.6% | -54.3% | -43.3% | -50.4% | -47.9% | -41.4% |
| Jun 1 | JP Morgan | Downgrade | Overweight → Neutral | — | $87.68 | $81.60 | -6.9% | -5.1% | -2.4% | -4.0% | -2.9% | +4.2% |
| May 15 | JMP Securities | Maintains | Market Outperform → Outperform | — | $101.76 | $102.40 | +0.6% | +12.1% | +7.4% | +4.9% | +1.6% | -1.3% |
| May 15 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $101.76 | $102.40 | +0.6% | +12.1% | +7.4% | +4.9% | +1.6% | -1.3% |
| May 10 | Wedbush | Maintains | Outperform → Outperform | — | $107.68 | $111.36 | +3.4% | +3.0% | -1.0% | -5.5% | +5.9% | +1.5% |
| May 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $107.68 | $111.36 | +3.4% | +3.0% | -1.0% | -5.5% | +5.9% | +1.5% |
| Mar 16 | Wedbush | Maintains | Outperform → Outperform | — | $123.36 | $118.88 | -3.6% | +0.0% | -3.6% | -16.9% | -14.8% | -22.4% |
| Mar 16 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $123.36 | $118.88 | -3.6% | +0.0% | -3.6% | -16.9% | -14.8% | -22.4% |
| Dec 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $276.32 | $173.60 | -37.2% | -39.6% | -37.5% | -38.4% | -42.4% | -45.6% |
| Sep 21 | JP Morgan | Maintains | Overweight → Overweight | — | $236.96 | $244.64 | +3.2% | -3.5% | -7.8% | -6.1% | -6.9% | -7.2% |
| Mar 31 | SMBC Nikko | Maintains | Outperform → Outperform | — | $313.12 | $314.24 | +0.4% | +2.0% | +6.3% | +1.2% | -1.8% | -1.0% |
| Mar 17 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $255.04 | $249.76 | -2.1% | +1.9% | +1.0% | -5.1% | +5.1% | +3.9% |
| Mar 8 | Truist | Maintains | Buy → Buy | — | $200.96 | $207.52 | +3.3% | +4.1% | +14.0% | +12.3% | +4.4% | -2.1% |
| Mar 4 | Jefferies | Maintains | Buy → Buy | — | $196.96 | $201.60 | +2.4% | +2.0% | +2.0% | +6.2% | +16.3% | +14.6% |
| Dec 6 | Guggenheim | Maintains | Buy → Buy | — | $156.80 | $218.40 | +39.3% | +38.5% | +47.9% | +56.0% | +40.2% | +41.7% |
No insider trades available.
Data updated apr 24, 2026 10:28am
· Source: massive.com